SA¹ú¼Ê´«Ã½

Tuesday 15 July 2025
Salisbury Foundation Trust

FOI_8598

Internal Reference Number: FOI_8598

Date Request Received: 17/04/2025 00:00:00

Date Request Replied To: 07/05/2025 00:00:00

This response was sent via: By Email

Request Summary: Multiple Myeloma

Request Category: Researcher



 
Question Number 1:
I have a freedom of information request regarding the treatment of Multiple Myeloma. Could you please answer the following questions.

Over the past 6 months, how many adult multiple myeloma [MM] patients have you treated? If you refer your multiple myeloma patients to another centre, please state which.
 
Answer To Question 1:
Please see attached excel

To accompany this answer to question 1 please also see the documents listed below:

 FOI_8598 - Multiple Myeloma.xlsx
 
Question Number 2:
Of the multiple myeloma patients treated over the past 6 months, how many were treated with the following:

• Any other systemic anti-cancer therapy

• Belantamab Mafodotin [Blenrep]

• Belantamab Mafodotin [Blenrep] with bortezomib and dexamethasone

• Belantamab Mafodotin [Blenrep] with pomalidomide and dexamethasone

• Bortezomib [Velcade] monotherapy or with dexamethasone

• Bortezomib [Velcade], Melphalan/Cyclophosphamide and prednisolone/dexamethasone (VMp or VCd)

• Bortezomib, thalidomide and dexamethasone [VTD]

• Carfilzomib [Kyprolis] and dexamethasone

• Carfilzomib [Kyprolis], Lenalidomide [Revlmid] and dexamethasone

• Daratamumab [Darzalex] with Lenalidomide [Revlimid] and dexamethasone

• Daratumumab [Darzalex] monotherapy

• Daratumumab [Darzalex], Bortezomib [Velcade] and dexamethasone (known as DVd or DBd)

• Daratumumab [Darzalex], Bortezomib [Velcade], thalidomide and dexamethasone (known as Dara-VTd)

• Elranatamab

• Idecabtagene vicleucel [Abecma]

• Isatuximab [Sarclisa], Pomalidomide [Imnovid] and dexamethasone (known as IsaPd)

• Ixazomib [Ninlaro], Lenalidomide [Revlmid] and dexamethasone (known as IRd)

• Lenalidomide [Revlimid] and dexamethasone

• Lenalidomide [Revlmid] monotherapy

• Panobinostat in combination with Bortezomib and Dezamethasone

• Pomalidomide [Imnovid] and dexamethasone

• Selinexor and dexamethasone

• Selinexor, Bortexomiv [Velcade] and dexamethasone

• Talquetamab

• Teclistamab [Tecvayli]
 
Answer To Question 2:
Please see attached excel
Please see Attachments:
 
To return to the list of all the FOI requests please click here

Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

SA¹ú¼Ê´«Ã½, SA¹ú¼Ê´«Ã½ Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2025 SA¹ú¼Ê´«Ã½
Trust Values